Login / Signup

Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.

Timothy M ReynoldsClare MewiesJohn HamiltonAnthony S Wierzbickinull null
Published in: Journal of clinical pathology (2018)
Pathology databases hold routine information that can be used to identify patients with specific patterns of results or those who had biopsies to allow targeted testing for possible causes of disease. Biochemical screening suggests that the gene frequency of LAL deficiency in adults is less than 1 in 100.
Keyphrases
  • clinical practice
  • quality improvement
  • genome wide
  • copy number
  • dna methylation
  • transcription factor
  • big data
  • drug delivery
  • deep learning